Invention Grant
- Patent Title: Highly efficient influenza matrix (M1) proteins
-
Application No.: US15287433Application Date: 2016-10-06
-
Publication No.: US09951317B2Publication Date: 2018-04-24
- Inventor: Gale Smith , Yingyun Wu , Michael J. Massare , Peter M. Pushko , Margaret Nathan , Thomas Kort , Robin Robinson
- Applicant: NOVAVAX, INC.
- Applicant Address: US MD Gaithersburg
- Assignee: NOVAVAX, INC.
- Current Assignee: NOVAVAX, INC.
- Current Assignee Address: US MD Gaithersburg
- Agency: Cooley LLP
- Main IPC: A61K39/145
- IPC: A61K39/145 ; C12N7/00 ; A61K39/12 ; C12N9/24 ; C07K14/005 ; A61K39/00
Abstract:
This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
Public/Granted literature
- US20170253861A1 HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS Public/Granted day:2017-09-07
Information query
